Viral Hepatitis
Copyright ©The Author(s) 2003.
World J Gastroenterol. Sep 15, 2003; 9(9): 1999-2003
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1999
Table 1 Changes of biochemical parameters of patients before and after treatment (-x±s)
GroupALT (u·L-1)
TBil (μmol·L-1)
Alb (g·L-1)
PTA (%)
BeforeAfterBeforeAfterBeforeAfterBeforeAfter
Control112.4 ± 37.298.5 ± 23.6315.1 ± 43.2263.7 ± 105.231.3 ± 5.132.5 ± 2.633.5 ± 4.743.5 ± 6.7
UCBT95.6 ± 31.984.3 ± 35.7376.3 ± 55.1203.1 ± 85.4bc30.6 ± 4.235.6 ± 2.4a31.5 ± 3.645.8 ± 5.4a
PE116.3 ± 44.181.9 ± 42.5356.6 ± 48.5195.6 ± 103.7bc28.5 ± 3.636.9 ± 5.1bc28.8 ± 7.248.3 ± 7.5b
UCBT+PE104.5 ± 38.685.3 ± 36.2405.7 ± 59.4173.2 ± 125.6bc30.7 ± 4.437.7 ± 3.5bc29.7 ± 6.552.3 ± 10.2bc
Table 2 Parameters of cellular and humoral immune of patients before and after treatment (-x±s)
GroupActive T lymphocyte (%)
CD4+ lymphocyte (%)
CD8+ lymphocyte (%)
IL2 (u·mL-1)
BeforeAfterBeforeAfterBeforeAfterBeforeAfter
Control35.6 ± 7.544.1 ± 14.332.7 ± 5.335.6 ± 8.222.5 ± 3.623.7 ± 5.241.3 ± 10.548.6 ± 21.5
UCBT33.2 ± 8.751.6 ± 12.5ab30.5 ± 6.944.3 ± 11.6a23.2 ± 4.725.6 ± 9.544.5 ± 9.662.7 ± 28.6ab
PE36.1 ± 6.342.7 ± 16.929.5 ± 8.234.7 ± 7.420.4 ± 6.926.7 ± 8.448.6 ± 11.351.3 ± 31.9
UCBT+ PE31.9 ± 8.558.9 ± 25.4ab27.1 ± 7.348.5 ± 21.3ab18.3 ± 8.528.4 ± 11.236.2 ± 10.864.8 ± 27.5ab
Table 3 Biochemical parameters of rats after treatment (-x±s)
GroupALT(u·L-1)TBil (μmol·L-1)AFP(μg·L-1)
Control group1025.3 ± 36.978.6 ± 3.421.5 ± 13.8
Normal saline group1016.8 ± 318.265.6 ± 18.323.7 ± 15.9
Adult plasma group365.6 ± 118.4a36.2 ± 9.5a28.9 ± 18.7
Neonate cord blood group186.7 ± 39.5bc14.3 ± 6.0bc686.4 ± 186.5bd
Table 4 Histological examinations of rats’ liver after treatment (-x±s)
GroupsBallooning degenerationFatty degenerationHepatocellular necrosisHepatocellular regeneration
Control group+++++++++--
Normal saline group+++++++++--
Adult plasma group+++++++
Neonate cord++++++
blood group